Abstract:Hypoxia is a common phenomenon among most solid tumors that significantly influences tumor response toward chemo- and radiotherapy. Understanding the distribution and extent of tumor hypoxia in patients will be very important to provide personalized therapies in the clinic. Without sufficient vessels, however, traditional contrast agents for clinical imaging techniques will have difficulty in accumulating in the hypoxic region of solid tumors, thus challenging the detection of hypoxia in vivo. To overcome this problem, herein we develop a novel hypoxia imaging probe, consisting of a hypoxia-triggered self-assembling ultrasmall iron oxide (UIO) nanoparticle and assembly-responding fluorescence dyes (NBD), to provide dual-mode imaging in vivo. In this strategy, we have employed nitroimidazole derivatives as the hypoxia-sensitive moiety to construct intermolecular cross-linking of UIO nanoparticles under hypoxia, which irreversibly form larger nanoparticle assemblies. The hypoxia-triggered performance of UIO self-assembly not only amplifies its T2-weighted MRI signal but also promotes the fluorescence intensity of NBD through its emerging hydrophobic environment incorporated into self-assemblies. In vivo results further confirm that our hypoxic imaging probe can display a prompt MRI signal for the tumor interior region, and its signal enhancement performs a long-term effective feature and gradually reaches 3.69 times amplification. Simultaneously, this probe also exhibits obvious green fluorescence in the hypoxic region of tumor sections. Accordingly, we also have developed a MRI difference value method to visualize the 3D distribution and describe the extent of the hypoxic tumor region within the whole bodies of mice. Due to its notable efficiency of penetration and accumulation inside a hypoxic tumor, our hypoxia imaging probe could also be considered as a potential candidate as a versatile platform for hypoxia-targeted drug delivery, and meanwhile its hypoxia-related therapeutic efficacy can be monitored.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/jacs.0c10245?goto=supporting-info">https://pubs.acs.org/doi/10.1021/jacs.0c10245</a>.Details of the synthesis, TEM images, in vivo and in vitro biocompatibility (<a class="ext-link" href="/doi/suppl/10.1021/jacs.0c10245/suppl_file/ja0c10245_si_001.pdf">PDF</a>)Three-dimensional (3D) distribution of hypoxic areas within the whole body of 4T1 in situ tumor-bearing mice calculated by the MRI difference value method, where the color moves from blue to red to indicate the hypoxic degree enhancement (<a class="ext-link" href="/doi/suppl/10.1021/jacs.0c10245/suppl_file/ja0c10245_si_002.mp4">MP4</a>)This article has not yet been cited by other publications.

[Prospect of Hypoxia Imaging of Nuclear Medicine in Tumors].

Positron Emission Tomography Imaging of Tumor Hypoxia

The Application of Hypoxia Imaging with PET in Predicting Tumor Hypoxia and Guiding Clinical Therapy

Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET

Imaging Agents in Targeting Tumor Hypoxia.

Recent advances on radionuclide labeled hypoxia-imaging agents.

Hypoxic Imaging with 99Mtc-Hl91 Single Photon Emission Computed Tomography in Advanced Nonsmall Cell Lung Cancer

PET Hypoxia Imaging and Progress of Enhancing Radio-Sensitivity in Hypoxic Tumor

Hypoxia-responsive fluorescent nanoprobe for imaging and cancer therapy

Advances in PET and MRI imaging of tumor hypoxia

Chemical Design And Synthesis Of Functionalized Probes For Imaging And Treating Tumor Hypoxia

Positron Emission Tomography Imaging Sheds New Light on Hypoxia and Antitumor Therapies

A Functional CT Contrast Agent for in Vivo Imaging of Tumor Hypoxia

Experimental Study on Roles of 99Mtc-Hl91 Imaging and Carbogen Breathing in 32P-Colloid Interstitial Treatment of Malignant Tumor

18F-HX4 Hypoxia Imaging with PET/CT in Head and Neck Cancer

Magnetic Resonance Imaging in Detection of Tumor Hypoxia

18F-HX4/18F-FMISO-based micro PET for imaging of tumor hypoxia and radiotherapy-associated changes in mice

Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers

Development of a Hypoxia-Activated Red-Emission Fluorescent Probe for in Vivo Tumor Microenvironment Imaging and Anti-Tumor Therapy

Hypoxia-Triggered Self-Assembly of Ultrasmall Iron Oxide Nanoparticles to Amplify the Imaging Signal of a Tumor

Tumor hypoxia and molecular imaging